Weight management is entering a new, more integrated era with Weight Watchers’ latest launch, a fully integrated support programme specifically designed for people using GLP-1 medications such as Ozempic, Wegovy and similar drugs. This marks a significant shift in how weight-loss medications and lifestyle-based support services are combined to help users achieve more sustainable and effective results.
What Are GLP-1 Medications?
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed to treat type 2 diabetes. They work by mimicking a naturally occurring hormone that slows gastric emptying, suppresses appetite, and can help reduce caloric intake. In recent years, drugs like Ozempic and Wegovy have become widely known for their role in weight loss, even beyond diabetes treatment.
While GLP-1 drugs can be effective on their own, researchers and healthcare professionals agree that medication works best when paired with structured lifestyle support, including personalised nutrition, physical activity guidance, behavioural strategies, and accountability, areas where Weight Watchers has decades of experience.
What Weight Watchers’ Programme Includes
Weight Watchers’ new GLP-1 Success Program is part of a broader platform called Weight Watchers Med+, designed as a comprehensive support system for people using these medications. The initiative combines medical prescribing with behavioural and nutritional coaching within an updated digital experience.
Key components include:
-
Personalised nutrition guidance: Helping members meet individual macronutrient and nutrient needs while appetite is reduced, ensuring balanced eating even with suppressed hunger.
-
Medication dose and progress tracking: Tools to monitor weight changes and GLP-1 usage alongside lifestyle habits.
-
Side-effect management strategies: Practical support for common experiences like nausea or digestive changes, which can occur with GLP-1 medications.
-
Strength-focused plans: To help preserve muscle mass during weight loss, a common concern for people on appetite-suppressing drugs.
-
Coaching and community support: Access to trained coaches and virtual groups with others on similar journeys, reinforcing habit change and long-term success.
This programme isn’t limited to people who get prescriptions through Weight Watchers’ own Med+ clinicians, it’s also offered as a standalone support option for members whose GLP-1 medications are prescribed externally, ensuring broad access to evidence-based lifestyle guidance.
A Modern, Tech-Enabled Experience
To support this integrated approach, Weight Watchers has also redesigned its digital platform with features tailored to the GLP-1 era. These include metrics like a Weight Health Score that tracks lifestyle inputs such as sleep, activity and eating habits, as well as an AI-powered body scanner that helps users monitor changes in body composition.
These features provide deeper insights than traditional weight tracking alone and help members understand how lifestyle changes and medication interact over time.
Why This Matters for Weight Management
The addition of structured support alongside GLP-1 medications responds to a growing need in modern weight management. Medications alone may reduce appetite or affect metabolism, but without guidance on balanced nutrition, movement and behaviour change, results may plateau or fail to last long term. By combining pharmacology with personalised lifestyle support, Weight Watchers aims to bridge that gap and help people sustain improvements in health, wellbeing, and body composition.
This shift also reflects broader trends in healthcare, where multimodal support, blending medication with coaching and tech-enabled tracking, is increasingly seen as a best practice approach for complex conditions like obesity.
References
-
Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era, Weight Watchers press release — Dec 16, 2025. corporate.ww.com
-
Weight Watchers Launches New Service Helping People Using Fat Jabs, The Sun UK — Dec 2025. The Sun
-
Insights from HLTH EU: Beyond the Hype — Future of GLP-1 Companion Programs, WW perspectives. business.weightwatchers.com
